• Bookmark and Share

Statement Issued About New Discovery

Last Updated on Friday, February 06, 2004

FEBRUARY 06, 2004 -  The Preeclampsia Foundation today issued a statement of cautious optimism about the new study to be published in next week's New England Journal of Medicine, indicating a unique protein marker is sharply elevated five weeks prior to the onset of preeclampsia.

Anne Garrett, Executive Director of the Preeclampsia Foundation, the nation's only patient advocacy organization dedicated to hypertensive disorders of pregnancy, said, "The study shows great promise that a definitive diagnostic tool could be developed to identify which pregnant women will develop this potentially life-threatening complication. While we are extremely excited that the cause of preeclampsia may have been discovered, a fact that has eluded medical experts for hundreds of years, we are especially hopeful that this may herald an increase in awareness and research funding for a cure. It is extremely important that science, academia and industry partner their resources to advance a proven therapy. The mortality rate from preeclampsia and related conditions for women and their babies is unacceptable.

 

UPCOMING EVENTS

We’ll be Speaking Here

  

  Association of Women's Health, Obstetric and Neonatal Nurses National Conference

June 24, 2018
Tampa, Florida

 

 HRSA Maternal Mortality Summit

 June 19-21, 2018

Rockville, MD

 

 

  Invite Us to Speak at Your Event

 

Featured Video

What’s Happening on Twitter

Preeclampsia CEO @Eleni_Z_Tsigas brings the patient voice into the discussion at #HRSAMaternalMortality; hear what she's got to… https://t.co/e2mEMCfFuy
Preeclampsia What should #preeclampsia patients expect from their healthcare providers? Check out the Hospital Guidelines and… https://t.co/kBmoN7Edta
Preeclampsia Join the live webcast 6/19-21 with Eleni Tsigas, CEO of @preeclampsia Foundation at #HRSA Experts from… https://t.co/ILQNGbO7ho

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.